ACTIVATING MUTATIONS OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA (PDGFRA) AS DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS:

Details for Australian Patent Application No. 2003276067 (hide)

Event Publications

19 February 2004 Complete Application Filed

Priority application(s): 60/389,107 13.06.02 US; 60/438,899 08.01.03 US

26 February 2004 Application Open to Public Inspection

Published as AU-A-2003276067

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 August 2005 Corrigenda

Applications OPI - Name Index Under the name OREGON HEALTH AND SCIENCE UNIVERSITY, Application No. 2003276067, under INID (71) correct the name to read OREGON HEALTH AND SCIENCE UNIVERSITY; DANA-FARBER CANCER INSITUTE; BRIGHAM AND WOMEN'S HOSPITAL; THE GOVERNMENT OF THE UNITED STATES d.b.a. THE DEPARTMENT OF VETERANS AFFAIRS

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.